Today: 5 June 2026

Marcin Frąckiewicz

CEO of TS2 Space and founder of TS2.tech. Expert in satellites, telecommunications, and emerging technologies, covering trends in space, AI, and connectivity.

Praxis Precision (PRAX) Stock Skyrockets on Game-Changing Phase 3 Results – What Experts Say

Praxis Precision Medicines (PRAX) Stock Skyrockets 180% on Game‑Changing Trial – Analysts See ‘Blockbuster’ Upside

Praxis Precision Medicines shares soared 183% to $162.71 on Thursday after its drug ulixacaltamide met all key goals in a Phase 3 trial for essential tremor. The results showed significant improvement in patient function and no serious side effects. The company plans to seek FDA approval by early 2026 and launched a public stock offering to fund commercialization.
17 October 2025
·
CSX CEO Abruptly Departs Amid Rail Merger Frenzy – What’s Next?

CSX Delivers Earnings Surprise: Stock Jumps as New CEO Navigates Rail Merger Frenzy

CSX shares rose about 3% to $36–$37 after reporting adjusted Q3 profit of $0.44 per share, beating expectations. Revenue matched forecasts at $3.59 billion as higher intermodal volumes offset weak coal demand. Net income fell 22% year-over-year due to one-time charges. The report marked Steve Angel’s first quarter as CEO following a recent leadership shakeup.
17 October 2025
····
Interactive Brokers Stock Soars After Q3 Earnings Beat, 40% Asset Surge

Interactive Brokers Stock Soars After Q3 Earnings Beat, 40% Asset Surge

Interactive Brokers reported Q3 net revenue of $1.66 billion and adjusted EPS of $0.57, both above analyst estimates. Shares closed at $68.52 on Oct. 16, up 83% over 12 months and 56% year-to-date, aided by a June stock split. Customer accounts jumped 32% to 4.13 million, and client equity rose 40% to $757.5 billion. The board declared a $0.08 quarterly dividend payable in December.
17 October 2025
··
BBVA Stock Jumps on Failed Takeover Bid – What’s Next for the Banking Giant?

BBVA Stock Jumps on Failed Takeover Bid – What’s Next for the Banking Giant?

BBVA’s €16 billion hostile takeover bid for Sabadell collapsed after only 25.5% of shares were tendered, below the required threshold. BBVA stock jumped on relief, with U.S.-listed ADRs surging 6–7% intraday on Oct. 16 as trading volume spiked. All major rating agencies upgraded BBVA in recent weeks, citing strong profits and capital. The bank announced a record interim dividend and will resume €1 billion in buybacks Oct. 31.
16 October 2025
··
KKR Stock Plunges 6% Amid Volatility – Analysts See ~25% Upside Ahead

KKR Stock Plunges 6% Amid Volatility – Analysts See ~25% Upside Ahead

KKR shares fell 6.8% on October 16, closing near $116 and now sit over 30% below their 52-week high. The company will report Q3 earnings on October 23, with analysts expecting $1.33 per share. KKR recently completed a €19 billion Telecom Italia network deal and is resisting a proposed merger with Open Fiber. Co-founder George Roberts sold about 810,000 shares this summer, netting $116.8 million.
16 October 2025
·
SoFi Stock Skyrockets 230% in 2025 – Will This Fintech Rally Last or Crash?

SoFi Stock Skyrockets Amid Fintech Frenzy – What’s Driving SOFI as Q3 2025 Looms?

SoFi Technologies stock has surged 230% in the past year, recently hitting a 52-week high near $30.30 before retreating to $27 as of Oct. 16. The company launched no-fee options trading and announced a partnership with Lightspark for blockchain-based remittances. Q2 net income reached $97 million, up from $8 million a year ago. Wall Street remains split, with price targets ranging from $12 to $31.
16 October 2025
··
Quantum Rocket or Bubble? RGTI’s Stunning Surge Explained—And How It Stacks Up to IonQ, D‑Wave, and QUBT

Rigetti’s Quantum Leap: Stock Skyrockets 5,000% Amid Deals & Hype – Bubble or Breakthrough?

Rigetti Computing shares surged 25% in a single day on Oct. 13, hitting a record high near $56 and pushing its market cap to almost $17 billion. The stock is up over 5,000% in the past year, despite annual revenue of just $8–10 million and ongoing losses. Analysts rate the stock a “Buy,” but average price targets remain far below current levels. Technical indicators show overbought conditions, with a recent 13% pullback after insider selling.
16 October 2025
···
Femasys (FEMY) Stock Soars 46% on Fertility Tech and FDA Milestones

Femasys (FEMY) Stock Soars 46% on Fertility Tech and FDA Milestones

Femasys (NASDAQ: FEMY) jumped 46% to $0.80 by mid-day Oct. 16 after announcing its FemaSeed fertility treatment will be showcased at ASRM 2025. The company recently secured European, UK, and New Zealand approvals for its FemBloc birth control device and reported its first European sales and new distribution deals. Q2 revenue rose 85% year-over-year to $0.409 million.
16 October 2025
··
Beyond Meat Stock CRASH: 60% Plunge After Shocking Debt Swap Stuns Investors

Beyond Meat Shares Plunge as Debt Restructure Sparks Panic

Beyond Meat shares fell 14% Wednesday to $0.67, near all-time lows after a debt-for-equity swap triggered a 60% plunge last week. Nearly 97% of its $1.15 billion notes will convert to new debt and 316 million shares, flooding the market after an Oct. 17 lockup expires. Q2 sales dropped 19.6% year-over-year, and analysts rate the stock a “Strong Sell.” The company holds $117 million cash against $1.2 billion in debt.
16 October 2025
·
INVO Fertility (NASDAQ: IVF) Stock Skyrockets 90% as Fertility Boom Fuels Frenzy

INVO Fertility (NASDAQ: IVF) Stock Skyrockets 90% as Fertility Boom Fuels Frenzy

INVO Fertility shares surged 89.6% to $1.43 on Oct. 16, with intraday highs of $2.03 and over 108 million shares traded—far above its 5.5 million share float. The rally follows a $200,000 preferred share sale and a recent SEC filing to register 8.35 million shares for resale. The company remains unprofitable and faces liquidity pressures. Year-to-date, the stock is up 95% but still trades 98% below its 52-week high.
16 October 2025
··
Jefferies Stock Rollercoaster: Earnings Beat, First Brands Fallout & Analyst Forecasts

Jefferies Stock Rollercoaster: Earnings Beat, First Brands Fallout & Analyst Forecasts

Jefferies Financial Group shares fell over 5% on Oct. 16 to their lowest level since June after news of shareholder lawsuits tied to its exposure to bankrupt First Brands Group. The stock is down about 25% in October and 37% year-to-date. Jefferies reported better-than-expected Q3 earnings, but costs surged nearly 20%. Japan’s SMBC is raising its stake to 20% in a $912 million deal announced last month.
16 October 2025
···
Costco Stock Surges Amid Retail Gloom – Will $900+ Shares Keep Climbing?

Costco (COST) Stock Slides to ~$924: Analyst Takeaways and Competitor Comparison (Oct 16, 2025)

Costco shares fell 3.4% to $924 on Oct. 16 despite fiscal Q4 net sales rising 8% to $84.4 billion and net income reaching $2.61 billion, both above forecasts. Same-store sales excluding gas increased 6.4%, and membership fee revenue jumped 14% to $1.72 billion. Walmart and Target also declined, while BJ’s Wholesale was flat. Wall Street’s 12-month price target for Costco averages $1,054.
16 October 2025
····
Aptera (SEV) Nasdaq Debut: Solar EV Startup’s Wild First Day, Key Takeaways and Outlook

Aptera (SEV) Nasdaq Debut: Solar EV Startup’s Wild First Day, Key Takeaways and Outlook

Aptera Motors (NASDAQ: SEV) opened at $20.42 in its Oct. 16 direct listing, surged to $22.43, then plunged to $3.63 before stabilizing near $9, giving it a $300 million market cap. The California EV startup, which has not delivered vehicles or posted revenue, secured a $75 million equity line after listing. Aptera reported a $22.9 million loss for H1 2025 and had about $13 million in cash midyear.
16 October 2025
··
Capital One Savers Cheated Out of Billions – $425M Settlement Payout Deadline Fast Approaching

Capital One Stock Plunges 6% Amid Settlement Showdown, Big Merger & Earnings Countdown

Capital One shares fell 5.9% to $202.42 on Oct. 16, erasing a week’s gains after legal and sector concerns. The drop follows a rally to $215 the day before. The bank faces scrutiny over a $425 million settlement and reports Q3 earnings Oct. 21. Capital One completed its $35.3 billion Discover takeover in May, becoming the largest U.S. card issuer.
16 October 2025
····
Zions Bancorp Stock Plunges 13% After Surprise $50M Fraud-Linked Loan Loss – Is More Trouble Ahead?

Zions Bancorp Stock Plunges 13% After Surprise $50M Fraud-Linked Loan Loss – Is More Trouble Ahead?

Zions Bancorporation said it will charge off $50 million on two business loans after finding “apparent misrepresentations and contractual defaults” by borrowers. The news sent ZION shares down 12–13% on Oct. 16, while the regional bank index fell nearly 4–6%. Western Alliance Bancorp shares dropped 11% after disclosing related exposure and a prior fraud lawsuit. Analysts questioned Zions’ risk controls and cut price targets.
16 October 2025
·
Recursion (RXRX) Stock Surges on AI-Driven Breakthroughs and Big-Pharma Deals

Recursion (RXRX) Stock Surges on AI-Driven Breakthroughs and Big-Pharma Deals

Recursion Pharmaceuticals shares surged 16% on Oct 8 after its CEO spoke at an AI conference, then traded around $6.50 intraday on Oct 16 with volume spiking to 86.9 million shares. The company reported Q2 revenue of $19.2 million and a net loss of $171.9 million, with $534 million in cash. Recursion focuses on oncology and rare disease drugs, recently acquiring Exscientia and licensing new assets.
16 October 2025
·
Kenvue (KVUE) Stock Plunges Amid Tylenol and Talc Fears – What’s Next?

Kenvue (KVUE) Stock Plunges Amid Tylenol and Talc Fears – What’s Next?

Kenvue shares hit a 52-week low of $15.46 on Oct. 16, 2025, down about 5% in one day and over 27% in the past year. The company faces new UK talcum-powder lawsuits and ongoing FDA scrutiny over Tylenol, while Q2 revenue fell 4% to $3.84 billion. Moody’s affirmed its A1 rating but cut the outlook to negative. Kenvue replaced its CEO in July and launched a strategic review, considering asset sales.
16 October 2025
·
1 … 257 258 259 260 261 … 386

Stock Market Today

  • Investors Respond to CSL's US$5bn Vifor Impairment and FY26 Guidance Cut
    June 5, 2026, 4:07 PM EDT. CSL Limited lowered its FY26 revenue guidance to US$15.2 billion and announced a significant US$5 billion non-cash impairment primarily linked to CSL Vifor, impacting investor confidence. The impairment reflects past capital allocation challenges and pressures on CSL's iron therapies segment. The company aims to achieve US$500-550 million in annual cost savings by FY28 through an operational transformation program. Despite these setbacks, CSL projects long-term revenue of US$17.2 billion and earnings of US$3.3 billion by 2029, suggesting a potential 49% upside to the current share price. Market analysts remain cautious amid reset expectations, underscoring risks related to Vifor's impaired returns and pricing pressures on CSL's core plasma, vaccines, and iron therapies franchises.

Latest articles

Oil Falls as Peace Talks Raise Hopes, Traders Brace for What’s Next

Oil Falls as Peace Talks Raise Hopes, Traders Brace for What’s Next

5 June 2026
Oil prices tumbled Friday as traders saw less risk of U.S.-Iran conflict escalation, with Brent settling at $93.09 and WTI at $90.54, down 2.04% and 2.69% respectively, even as global oil inventories hit “unheard of” lows and analysts warn a prolonged disruption could trigger a second price shock if summer demand drains remaining stockpiles.
TerraVest Shares Drop 30% After Chairman Allegations

TerraVest Shares Drop 30% After Chairman Allegations

5 June 2026
TerraVest shares plunged over 30% to a 52-week low after the board launched a review into allegations that Executive Chairman Charles Pellerin shared privileged information before the EnTrans deal, with Quebec’s AMF suspecting C$6.8 million in illicit gains; no charges have been filed, but the governance shock triggered a sharp, high-volume selloff.
AT&T Shares Rebound as SpaceX Threat Stays Front and Center

AT&T Shares Rebound as SpaceX Threat Stays Front and Center

5 June 2026
AT&T shares rose 1.1% to $23.02 Friday, rebounding from this week’s selloff as Oppenheimer warned SpaceX’s Starlink could disrupt the $1.6 trillion U.S. communications industry, cutting AT&T’s rating and removing its $32 price target; investors now weigh steady fiber and cash returns against risks from Starlink’s June 12 Nasdaq debut at a $1.75 trillion valuation.
Peso falls after U.S. jobs surprise resets Fed expectations

Peso falls after U.S. jobs surprise resets Fed expectations

5 June 2026
The Mexican peso tumbled over 1% to 17.47 per dollar after a stronger-than-expected U.S. jobs report boosted Treasury yields and the greenback, erasing Thursday’s rally and raising odds of a Fed rate hike this year, with investors shifting away from emerging-market currencies.
Go toTop